SUMMARY Sixteen outpatients with rheumatoid arthritis took part in a placebo controlled doubleblind crossover study. In addition to conventional measurements, a radioactive index was measured using a gamma camera that indicated a radioactive count over the measured joints and a comparable area of normal adjacent bone. This index showed poor correlation with other conventional measurements of change in the clinical trial.
Clinical trials of drugs that have an effect in rheumatology must use protocols that contain accepted measures of inflammation. This implies gross inflammation and change in inflammation. Any new measure must be validated by means of comparison with other measures in a clinical trial in order to assess its sensitivity. All the current clinical measures ofpain and inflammation used are subjective to some degree except perhaps ring size, but it may well be unrealistic to expect much change in this measure in a short clinical trial although everyone continues to use this technique.
Hence there is still a need for objective criteria for assessment. Two techniques have been studied in the past-thermography and radioisotope scanning (Cosh et al., 1970; Dick et al., 1970) . Thermography does not readily reflect change (Huskisson et al., 1973) . Using a conventional counter, radioisotope studies, while they reflect gross inflammation, are poor reflectors of change (Berry et al., 1974) . In this study an attempt has been made to increase the sensitivity of radioisotope scanning using a gamma camera which gives a print-out record of the scanning picture, indicating by colour the height of radioactive count.
Patients
Sixteen outpatients attending the department of rheumatology were taking part in a double-blind, controlled two-way crossover study in which they received new drug X or placebo. These Radioisotope scanning using a gamma camera 77 
